Brighton Jones LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$148K Buy
29,309
+8,156
+39% +$41.3K ﹤0.01% 877
2025
Q1
$112K Buy
21,153
+892
+4% +$4.72K ﹤0.01% 672
2024
Q4
$137K Buy
20,261
+6,699
+49% +$45.3K ﹤0.01% 657
2024
Q3
$89.4K Buy
+13,562
New +$89.4K ﹤0.01% 562